RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B

A. Mangia, O. Dalgard, N. Minerva, Hans Verbaan, G. Scotto, D. Bacca, E. Agostinacchio, K. Bjoro, V. Carretta, V. Piazzolla, R. Cozzolongo, M. Romano, L. Mottola, A. Andriulli

Research output: Contribution to journalPublished meeting abstractpeer-review

Original languageEnglish
Pages (from-to)S232
JournalJournal of Hepatology
Volume50
Issue numberSuppl 1
DOIs
Publication statusPublished - 2009
Event44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver - Copenhagen, Denmark
Duration: 2009 Apr 222009 Apr 26

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)

Subject classification (UKÄ)

  • Gastroenterology and Hepatology

Cite this